EBX-102-02 was well tolerated and led to clinically meaningful improvements across multiple symptom domains in patients with IBS-C.
Anthony Hobson, MPhil, PhD
Advertisement
Anthony Hobson, MPhil, PhD, is clinical director and senior clinical GI scientist at The Functional Gut Clinic and founder of Tummy MOT.
Articles by Anthony Hobson, MPhil, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Odevixibat Fails to Improve Native Liver Survival in Phase 3 BOLD Trial for Biliary Atresia
2
Omalizumab Outperforms Multiallergen OIT for Multifood Allergy
3
Survey Reveals Low Awareness of Chronic Hepatitis B’s Link to Liver Cancer
4
Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment
5